SynthesisPathogens and global health2022
Global meta-analysis on
Synthesis in Pathogens and global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Mapping the Global Distribution ofTransboundary and emerging diseases · 2025Pooled it
- Integrated Molecular and Hematobiochemical Biomarkers for the Detection of Bovine Babesiosis in Holstein Calves.Veterinary sciences · 2026Article
- Photo Quiz: A camper with fever, headache, and fatigue.Journal of clinical microbiology · 2026Article
- More than malaria: ExploringCurrent research in parasitology & vector-borne diseases · 2026Review
- Urban surveillance ofFrontiers in veterinary science · 2026Article
- A Set of Rapid Diagnostic Tool for Babesia microti Infection.Journal of clinical laboratory analysis · 2025Article
- Global prevalence ofNew microbes and new infections · 2025Article
- Human babesiosis: The past, present and future.Expert reviews in molecular medicine · 2025Review
- First Molecular Identification of ZoonoticMicroorganisms · 2025Article
- Targeted Tick-Borne Disease Recognition: Assessing Risk for Improved Public Health.Healthcare (Basel, Switzerland) · 2024Article
- Babesia BdFE1 esterase is required for the anti-parasitic activity of the ACE inhibitor fosinopril.The Journal of biological chemistry · 2023Article
- Transfusion-transmittedJournal of clinical microbiology · 2023Review
- Article
- A high-resolution melting approach for the simultaneous differentiation of five human babesiosis-causing Babesia species.Parasites & vectors · 2023Article
- Babesiosis concurrent with multiple abscesses fromHeliyon · 2023Article
- Nucleic Acid Prevalence of ZoonoticTropical medicine and infectious disease · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human babesiosis is an emerging tick-borne protozoan zoonosis caused by parasites of the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.